Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 0.00% is 100% above its 5-year average of -1942.04%, near the high end of its 5-year range (-10586.14%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
-1942.04%
NET PROFIT MARGIN AVG 10Y
-2802.45%
NET PROFIT MARGIN AVG 15Y
-2695.72%
NET PROFIT MARGIN AVG 20Y
-2049.06%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 525 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$5.40M
Net Profit Margin
-612568.11%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.48M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.47M
Net Profit Margin
-294.91%
TTM Avg
-320.57%
3Y Avg
-453.36%
5Y Avg
-361.46%
Market Cap
$5.25M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.59M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.01M
Net Profit Margin
-106.78%
TTM Avg
-43.08%
3Y Avg
-12.30%
5Y Avg
-12.30%
Market Cap
$5.83M
Net Profit Margin
-225.28%
TTM Avg
-379.90%
3Y Avg
-549.78%
5Y Avg
-669.44%
Market Cap
$4.84M
Net Profit Margin
-4011.86%
TTM Avg
-2005.93%
3Y Avg
-2671.67%
5Y Avg
-1781.12%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Imunon, Inc. (IMNN) | $5.38M | 0.00% | 0.00% | 0.00% | -1942.04% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.40M | -612568.11% | 0.00% | 0.00% | 0.00% |
| Alzamend Neuro Inc (ALZN)vs › | $5.48M | 0.00% | 0.00% | 0.00% | 0.00% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.47M | -294.91% | -320.57% | -453.36% | -361.46% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.25M | 0.00% | 0.00% | 0.00% | 0.00% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.59M | 0.00% | 0.00% | 0.00% | 0.00% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.01M | -106.78% | -43.08% | -12.30% | -12.30% |
| Lucyd, Inc (LUCY)vs › | $5.83M | -225.28% | -379.90% | -549.78% | -669.44% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.84M | -4011.86% | -2005.93% | -2671.67% | -1781.12% |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.83M | -3985.58% | -1467.13% | -2181.72% | -1717.85% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | -10586.14% |
| 2022-09-30 | -4918.63% |
| 2022-06-30 | -4834.35% |
| 2022-03-31 | -8379.47% |
| 2021-12-31 | -3377.04% |
| 2021-09-30 | -4328.44% |
| 2021-06-30 | -4358.72% |
| 2021-03-31 | -4551.20% |
| 2020-12-31 | -2409.72% |
| 2020-09-30 | -6457.28% |
| 2020-06-30 | -4274.35% |
| 2020-03-31 | -4045.50% |
| 2019-12-31 | -2482.21% |
| 2019-09-30 | -4381.45% |
| 2019-06-30 | -4723.61% |
| 2019-03-31 | -1893.96% |
| 2018-12-31 | 4384.46% |
| 2018-09-30 | -3725.11% |
| 2018-06-30 | -6584.44% |
| 2018-03-31 | -3581.60% |
| 2017-12-31 | -3744.67% |
| 2017-09-30 | -4537.06% |
| 2017-06-30 | -3911.90% |
| 2017-03-31 | -4128.11% |
| 2016-12-31 | -4317.27% |
| 2016-09-30 | -5127.75% |
| 2016-06-30 | -3624.79% |
| 2016-03-31 | -4573.17% |
| 2015-12-31 | -4411.09% |
| 2015-09-30 | -3413.93% |
| 2015-06-30 | -4539.80% |
| 2015-03-31 | -5604.05% |
| 2014-12-31 | -5164.64% |
| 2014-09-30 | -5553.88% |
| 2014-06-30 | -5338.74% |
| 2014-03-31 | -4338.15% |
| 2013-12-31 | -3159.80% |
| 2013-09-30 | -3257.22% |
| 2013-06-30 | 336.71% |
| 2013-03-31 | -520.78% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | -188.21% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | -80.66% |
| 2006-12-31 | -24.28% |
| 2006-09-30 | -24.04% |
| 2006-06-30 | -1217.43% |
| 2006-03-31 | -76.01% |
| 2005-12-31 | -48.86% |
| 2005-09-30 | -60.95% |
| 2005-06-30 | -83.00% |
| 2005-03-31 | -117.82% |
| 2004-12-31 | -220.35% |
| 2004-09-30 | -613.58% |
| 2004-06-30 | -332.23% |
| 2004-03-31 | -6065.68% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
